Recovery Force Receives Prestigious $1.8M Grant from National Institutes of Health

by Recovery Force Health | Apr 1, 2019 | Press Release

FISHERS, Ind.–(BUSINESS WIRE)–Recovery Force, LLC, a med tech innovation company, has received a $1.8 million grant from the National Institutes of Health (NIH) to complete development and clinically validate its flagship product, the Movement And Compressions™ (previously known as Mobile Active Compressions) (MAC) calf device. The innovative device is designed to prevent occurrences of Deep Vein Thrombosis (DVT) while facilitating faster patient mobility and recovery as well as collection of meaningful data for nurses and physicians.

The prestigious grant was awarded through NIH’s highly competitive Small Business Innovation Research (SBIR) process and builds off efforts from a previous $244,000 grant from NIH, which demonstrated the need for a new way to address DVT prevention and patient adherence. DVT is a life-threatening condition that affects between 350,000 to 600,000 people annually and is associated with $6B in yearly healthcare costs.

Mayo Clinic Ventures Partners with Wearable Medtech, Recovery Force

by Recovery Force Health | Feb 7, 2018 | Press Release

The Mayo Clinic’s venture capital and commercialization arm has established a relationship with an Indiana-based wearable medtech startup seeking to revolutionize how compression is used to prevent deadly blood clots.
 
Recovery Force LLC of Fishers, Indiana revealed last week it had set up a collaboration with the Rochester institution to be “managed” by Mayo Clinic Ventures. The Mayo division is in charge of commercializing clinic-developed research as well as making equity investments in companies deemed promising for improving patient care.
 
The announcement didn’t specify if a venture capital investment was part of the new collaboration. However, it did outline how under the agreement Recovery Force and Mayo will work together to develop new products using the company’s patented, shape-changing technology which is embedded into discrete, wearable garments and used to exert compression on the legs to prevent clots and deep-vein thrombosis.